Purpose To study the efficacy of topical cyclosporin A in children with vernal keratoconjunctivitis in a prospective randomised double-masked trial.
Topical cyclosporin, Vernal keratoconjunctivitis
Vernal keratoconjunctivitis is a seasonal form of allergic conjunctivitis associated with severe itching, photophobia, redness and tenacious discharge affecting children and young adults.
Remission generally occurs in the late teens. 
Statistical analysis
We used Fisher's (two-tailed) exact test for the dichotomous data for assessment of the ratings by the patients. Continuous variables were compared by a two-sample t-test. Eleven of the 12 (91%) patients in the CsA group had mild to marked improvement in symptoms which became evident by the first week of follow-up, in contrast to only 4 of the 12 (25%) in the placebo group who showed mild improvement of their symptoms (p < 0.05) (Fig. 1) . One patient in the CsA group who did not show any change in his symptoms even after 2 months was put on 4% sodium cromoglycate and 0. 1% dexamethasone eye drops. The 9 patients in the placebo group who were deemed treatment failures were also offered alternative treatment.
Eight of 12 patients (66%) in the CsA group showed varying degrees of papillary regression and 4 of these patients were disease-free at the 4 month follow-up. However, only 2 patients (16%) in the placebo group had mild improvement in their clinical signs (p < 0.05) (Fig. 2) . The most common side-effect was stinging (10 esA, 11 placebo) and redness of the eyes (6 esA, 11 placebo) a few minutes after instilling the medication. Other side effects included tearing (6 esA, 8 placebo) and transient blurring of vision (1 esA, 3 placebo). None of the patients developed an allergic reaction or esA-related corneal epitheliopathy. Side-effects were not severe enough for any patient to discontinue the medication.
The 2 boys in the esA group with shield ulcer (Fig. 3) received treatment for 5 months without any complaints severe enough to require discontinuation of the drops. patients remained free of disease. This was probably due to the fact that they recruited patients with severe vernal keratoconjunctivitis who had been symptomatic for from
Discussion

